SB2330 would amend the Unified Code of Corrections to require the Illinois Department of Corrections to screen all people in its custody for substance use disorder, including opioid use disorder, and to ensure access to medication-assisted treatment (MAT) when clinically appropriate. The bill defines MAT broadly as FDA-approved medications used with counseling and behavioral therapies, and it directs the Department to offer or facilitate access to all MAT options recommended by an authorized health care professional.
The bill also protects continuity of care for people who were already receiving MAT before incarceration by allowing them, upon request, to continue treatment for as long as medically necessary. It further bars the Department from denying MAT based on a positive drug screen at intake, from disciplining someone for that positive screen, or from excluding someone because they previously succeeded or failed in a MAT program. In addition, the Department would have to develop parole-district plans to help people with opioid use disorder access MAT after release, and it may adopt rules to implement these requirements, with an effective date of January 1, 2026.
Impact
If enacted, SB2330 would create a new statutory section in the Unified Code of Corrections and impose affirmative duties on the Department of Corrections regarding screening, treatment access, and reentry planning for incarcerated people with substance use disorders. It would expand access to medication-assisted treatment in correctional facilities, limit the Department’s ability to restrict treatment options, and require continuity of care for individuals entering custody while already on MAT. The bill would also affect parole-related reentry services by requiring community access plans in each parole district.
Sentiment
The bill’s stated purpose and findings reflect strong support for evidence-based treatment of opioid use disorder in correctional settings, emphasizing reduced recidivism, lower overdose risk, and continuity of care. The available record shows no committee transcripts or recorded votes, so there is no documented opposition or amendment debate in the provided materials. Overall, the bill appears to be framed as a public health and reentry measure with a pro-treatment, pro-continuity-of-care orientation.
Contention
The main policy tension inherent in the bill is between expanding medically directed MAT access and limiting correctional discretion over treatment administration. Potential points of contention include the requirement to provide all clinically appropriate MAT options, the prohibition on denying treatment due to a positive intake drug screen, and the ban on disciplinary consequences for that screen. Another possible area of debate is the operational and cost burden on the Department of Corrections and parole districts to implement screening, treatment, and post-release access plans. No specific opposing arguments are documented in the provided record.